Hepatitis A

Selected References:

  • Celzo F et al. 2020 Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy. Vaccine. 38(40):6215-6223.
  • Chilaka VN, Konje JC. 2020. Viral Hepatitis in Pregnancy. Eur J Obstet Gynecol Reprod Biol. 256:287-296.
  • Cho GJ, et al. 2013. Hepatitis A virus infection during pregnancy in Korea: Hepatitis A infection on pregnant women. Obstet Gynecol Sci, 56(6):368-374.
  • D’Acremont V, et al. 2008. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med 15(2):77-81.
  • Daudi N, et al. 2012. Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection. Breastfeed Med, 7:313-315.
  • Duff P. 1998. Hepatitis in Pregnancy. Seminars in Perinatology, 22(4):277-283.
  • Elinav E, et al. 2006. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology, 130(4):1129-1134.
  • Groom HC, et al. 2019. Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study. Vaccine, 37(44):6648-6655.
  • Lemon SM. 1997. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem, 43(8(B)):1494-1499.
  • Motte A, et al. 2009. Acute hepatitis A in pregnant women at delivery. Int J infect Dis, 13(2):e49-51.
  • Ornoy A, Tenenbaum, A. 2006. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio, and encephalitis viruses. Reprod Toxicol, 21(4):446-457.
  • Panagiotou OA, et al & Costa Rica HPV Vaccine Trial (CVT) Group. 2015. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ 351:h4358457.
  • Selander B, et al. 2009. No evidence of intrauterine transmission of hepatitis A virus from a mother to a premature infant. Acta Paediatr, 98(10):1603-1606
  • Seto MT, et al. 2020. Management of viral hepatitis A, C, D and E in pregnancy. Best Pract Res Clin Obstet Gynaecol, 68:44-53.

Hepatitis A

Selected References:

  • American Veterinary Medical Association. 2020. Salmonella: Amphibians and Reptiles FAQ. Available at: https://www.avma.org/salmonella-amphibians-and-reptiles-faq. Accessed 10 Dec 2024.
  • UCenter for Disease Control and Prevention. 2020. Salmonella. Available at: https://www.cdc.gov/salmonella/index.html. Accessed 10 Dec 2024.
  • Chen TL, et al. 2005. First Report of Salmonella enterica Serotype Panama Meningitis Associated with Consumption of Contaminated Breast Milk by a Neonate. J. Clin. Microbiol. 43(10), 5400–5402.
  • Delcourt C, et al 2019. Salmonella enteritidisduring pregnancy, a rare cause of septic abortion: case report and review of the literature. J. Obstet. Gynec., 39(4), 554–555.
  • EFSA BIOHAZ Panel, Koutsoumanis K, et al. 2019. Salmonella control in poultry flocks and its public health impact. EFSA J. 17(2): e05596.
  • Ficara M, et al. 2019. Unusual meningitis caused by non-typhoid Salmonella in an Italian infant: a case report. Acta Biomed. 90(2):333-338.
  • gov, 2019. Bacterias and Viruses. Available at: https://www.foodsafety.gov/food-poisoning/bacteria-and-viruses#salmonella. Accessed 10 Dec 2024.
  • Harb A, et al. 2017. Prevalence, risk factors and antimicrobial resistance of Salmonella diarrhoeal infection among children in Thi-Qar Governorate, Iraq. Epidemiol Infect. 145(16): 3486–3496. Johnson LR, et al. 2011. Salmonella infections associated with international travel: a Foodborne Diseases Active Surveillance Network (FoodNet) study. Foodborne Path. Dis. 8(9), 1031–1037.
  • Karabay, M., Sehmusoglu, Z., Terzi, H.A., et al. 2021. Neonatal Sepsis due to Salmonella enteritidis from Colonized Breast Milk; A Case Report and Literature Review of Breast Milk-induced Neonatal Sepsis. Flora, 26(2), 323-327.
  • March of Dimes. 2016. Food Poisoning During Pregnancy https://www.marchofdimes.org/complications/food-poisoning-during-pregnancy.aspx
  • Mollo, B., et al. 2019. Intrauterine infection caused by nontyphoidal Salmonella: a literature review. L-Fetal Neonatal Med 1–5.
  • Perry ID, et. al. 2019. Analysis of the capacity of Salmonella enterica Typhimurium to infect the human Placenta. Placenta, 83, 43–52.
  • S. Centers for Disease Control and Prevention. 2019. Bacterial Meningitis. Available at: https://www.cdc.gov/meningitis/about/bacterial-meningitis.html. Accessed 10 Dec 2024.
  • S. Centers for Disease Control and Prevention. 2020. Salmonella. Available at: https://www.cdc.gov/salmonella/index.html. Accessed 10 Dec 2024
  • Singhal V, et al. 2012. Neonatal Salmonella typhi meningitis: a rare entity. JCDR, 6(8), 1433–1434.
  • Smith J. 1999. Foodborne Infection during Pregnancy. J Food Prot. 62(7): 818–829
  • Tam C, et al. 2010. Food-borne illnesses during pregnancy: Prevention and treatment. Can Fam Physician. 56(4): 341-343.
  • Williamson CS. 2006. Nutrition in Pregnancy. Nutrition Bulletin.31(1):28-59

Hepatitis A

Selected References:

  • DeSisto CL, et al. 2021. Risk of stillbirth among women with and without COVID-19 at delivery hospitalization – United States, March 2020 – September 2021. MMWR Morb Mortal Wkly Rep 70:1640–1645.
  • Kasehagen L, et al. 2021. COVID-19 – associated deaths after SARS-CoV-2 infection during pregnancy – Mississippi, March 1, 2020 – October 6, 2021. MMWR Morb Mortal Wkly Rep 70:1646–1648.
  • Merck & Co., Inc. 2021. Center for Drug Evaluation and Research Antimicrobial Drugs Advisory Committee Meeting Briefing Document. Molnupiravir. Available at https://www.fda.gov/media/154421/download
  • Regan AK, et al. 2022. SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: a national US cohort study. J Infect Dis 225(5):759-767.
  • S. Food & Drug Administration, Antimicrobial Drugs Advisory Committee. November 30, 2021. Molnupiravir. Available at https://www.fda.gov/media/154472/download
  • U.S. Food & Drug Administration. 2021 (Revised October 2023). Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir. Available at https://www.fda.gov/media/155054/download

Hepatitis A

Selected References:

  • Aleem M, et al. 2005. Hyperprolactinemia affects spermiogenesis in adult male rats. Journal of Endocrinological Investigation 28(1):39-48.
  • Auerbach JG, et al. 1992. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 14(6):399-406.
  • Cleary MF. 1977. Fluphenazine decanoate during pregnancy. Am J Psychiat 134:815-816.
  • Donaldson GL, Bury RG. 1982. Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy. Acta Paediatr Scand 71:335-338.
  • Einarson A, Boskovic R. 2009. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 15(3):183-192.
  • 2011. Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns (issued 2/2011). https://www.fda.gov/Drugs/DrugSafety/ucm243903.htm
  • 2018. Retrieved from https://toxnet.nlm.nih.gov/cgi-bin/sis/search2
  • Gill-Sharma MK, et al. 2003. Antifertility effects of fluphenazine in adult male rats. Journal of Endocrinological Investigation 26(4):316-326.
  • Gomez EA. 1981. Hypersexuality in men receiving fluphenazine decanoate (letter). Am J Psychiatry 138:1263.
  • Holt RI, Peveler RC. 2011. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management. Clin Endocrinol (Oxf) 74(2):141-147.
  • King JT, et al. 1963.Perinatal findings in women treated during pregnancy with oral fluphenazine. J New Drugs ;3:21-5
  • Kopf GS, Vacquier VD. 2011. Characterization of a calmodulin-stimulated adenylate cyclase from abalone spermatozoa. J Biol Chem 259:7590-7596.
  • Maguire GA. 2002. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psychiatry 63(suppl 4):56-62.
  • Martinez JE, Wertelecki W. 1999. Schizophrenia and fluphenazine teratogenicity. Teratology 59:398.
  • Merlob P, et al. 1994. Is fluphenazine a teratogen? Am J Med Genet 52:231-232.
  • Mogwitz S, et al. 2018. Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents. ACS Chem Neurosci 9(4):651-672.
  • Nath SP, et al. 1996. Severe rhinorrhea and respiratory distress in a neonate exposed to fluphenazine hydrochloride prenatally. Ann Pharmacotherapy 30:35-37.
  • Rumeau-Rouquette C, et al. 1977. Possible teratogenic effect of phenothiazines in human beings. Teratology15:57-64.
  • Serres C, Kahn ML. 1984. Motility induction in hamster spermatozoa from caput epididymis: effect of forward motility protein (FMP) and calmodulin inhibitor. Reprod Nutr Dev 24:81-94.
  • Siragusa S, et al. 2022. Fluphenazine. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;. https://www.ncbi.nlm.nih.gov/books/NBK459194/.

Hepatitis A

Selected References

  • Blandthorn J, et al. 2018. Managing opioid overdose in pregnancy with take-home naloxone. Aust N Z J Obstet Gyneacol 58(4):460-62.
  • Debelak K, et al. 2013. Buprenorphine + Naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict; 22(3):252-54.
  • Flannagan KS, et al. 2020. Prescription opioid use among populations of reproductive age: effects on fertility, pregnancy loss, and pregnancy complications. Epidemiologic reviews. 42(1): 117-33.
  • Gawronski KM, et al. 2014. Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone. 2:2050312114530282.
  • Goshgarian G, et al. Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan. Cureus.14(8).
  • Griffiths S, et al. 2021. Use of injectable opioid agonist therapy in a in-patient setting for a pregnant patient with opioid use disorder: A case report. Journal of Addiction Medicine. 15(5): 435-38.
  • Jones HE & Kraft WK. 2019. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome. Clin Perinatol; 46(2):349-366.
  • Jansson LM, et al. 2024. Buprenorphine-Naloxone Maintenance and Lactation. Journal of Human Lactation 40(1): 113-19.
  • Jumah NA, et al. 2016. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. BMJ Open; 6(10):e011774.
  • Kanervo M, et al. 2023. Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder. Acta Obstetricia et Gynecologica Scandinavica. 102(3): 313-22.
  • Kanervo M, et al. 2024. Intrauterine exposure to maternal opioid maintenance treatment and associated risk factors may impair child growth. Acta Paediatrica.
Hepatitis A
April 1, 2024		 trang {PAGENO} / {PAGETOTAL}